July 2025 - Page 17 of 18

WednesdayJul 02, 2025 9:45 am

Adageis: An AI-Powered Advocate for Healthcare Providers

Adageis, a company offering a powerful and patented AI-centric software solution, remains committed to streamlining the healthcare sector, making it easier for providers to meet their financial goals It works with over 90 Electronic Health Record platforms, an unrivalled level of access that gives its users actionable insights at the point of care The company covers over 260,000 patient lives, and looks to double that to 580,000, achieving its $100,000 monthly recurring revenue target Adageis, a company offering powerful and patented AI-based software, provides flexible healthcare and related software solutions for providers and healthcare systems. The company remains committed to…

WednesdayJul 02, 2025 9:20 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Attracts Family Office Investors as Juve Stabia Valuation Soars 245%

Brera Holdings (NASDAQ: BREA), an Ireland-based company executing a multi-club football ownership strategy, announced strong interest from family office investors, with eight participating in its recently closed Series A Preferred Offering. The news follows rising FO investment in professional sports, highlighted by a June 26 FON Media report. Brera’s portfolio club, S.S. Juve Stabia, saw its valuation jump 245% to $32 million during the 2024–25 season, the highest increase in Italy’s Serie B, driven by the club’s deep playoff run. The surge reflects the early success of Brera’s ownership model and growing appeal to strategic private capital. To view the…

WednesdayJul 02, 2025 9:10 am

QualityStocksNewsBreaks – Lelantos Holdings, Inc. (OTC PINK: LNTO) Gains OTC Level 2 Quotation, Approved for Improved Disclosure Service

Lelantos Holdings (OTC PINK: LNTO) has qualified for OTC Level 2 quotations on the OTC Markets platform, enhancing real-time trading visibility and market transparency for investors. Level 2 access provides detailed bid and ask data across all market makers, offering deeper insight into stock activity. CEO Nathan Puente called the milestone a key step in the company’s capital markets strategy. Lelantos also received approval to join OTC Markets’ Improved Disclosure Service starting July 2025, a move COO Joshua Weaver said reflects the company’s commitment to transparency, regulatory alignment, and long-term investor trust. To view the full press release, visit https://ibn.fm/Mg6SM…

WednesdayJul 02, 2025 9:00 am

QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Joins Russell Microcap Index Following June Reconstitution

Safe Pro Group (NASDAQ: SPAI) an emerging provider of AI-powered security and threat detection solutions, has been added to the Russell Microcap(R) Index, effective after market close on June 27, 2025, as part of the index's annual reconstitution. The inclusion reflects the company's growing market profile and will increase its visibility among institutional investors and index-tracking funds. Safe Pro Chairman and CEO Dan Erdberg called the milestone a key step in the company’s expansion, citing the relevance of its AI and drone technologies in defense, security, and humanitarian applications. To view the full press release, visit https://ibn.fm/5tjnF About Safe Pro…

WednesdayJul 02, 2025 9:00 am

Soligenix Inc. (NASDAQ: SNGX) Highlights Encouraging Phase 3 Progress for HyBryte(TM) in Investment Webinar

A focus during the webinar was the investigator-initiated study currently being conducted at the University of Pennsylvania under the leadership of Dr. Ellen Kim. Interim results show that among the first eight patients who completed 18 weeks of treatment, 75% demonstrated a greater than 50% reduction in disease severity. Soligenix anticipates top-line results from the phase 3 trial in the second half of 2026. In a recent webinar hosted by Allele Capital, Soligenix (NASDAQ: SNGX) executives Dr. Christopher Schaber and Dr. Christopher Pullion shared detailed updates on the company's HyBryte(TM) (synthetic hypericin) clinical development (https://ibn.fm/dz7eO). The event offered an in-depth…

TuesdayJul 01, 2025 9:45 am

Silvercorp Metals Inc. (NYSE-A: SVM) (TSX: SVM) Updated Resource Estimate for Condor Project Highlights High-Grade Underground Potential

Total indicated underground mineral resources of 3.17 million tonnes at Camp and Los Cuyes deposits, containing 0.37 million gold equivalent ounces at a cutoff grade of 2.2 g/t AuEq. Total inferred underground mineral resources of 12.1 Mt at Camp and Los Cuyes deposits, containing 1.50 million gold equivalent ounces at a cutoff grade of 2.2 g/t AuEq. Ongoing 3,500-metre drill program set to expand known mineralization zones. Preliminary Economic Assessment for underground operation expected by year-end 2025. El Domo Project development on track with detailed cost breakdown and construction timeline targeting 2026 production. Silvercorp Metals (NYSE-A: SVM) (TSX: SVM), a…

TuesdayJul 01, 2025 9:40 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Added to Four Russell Indexes in 2025 Reconstitution

Nutriband (NASDAQ: NTRB) has been added to the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Indexes as part of the 2025 Russell indexes reconstitution. CEO Gareth Sheridan called the inclusion a reflection of market recognition and momentum behind the company’s AVERSA pipeline, particularly AVERSA Fentanyl, which has potential peak annual U.S. sales between $80 million and $200 million. Russell indexes, maintained by FTSE Russell, benchmark approximately $10.6 trillion in assets and are widely used by investment managers and institutions. To view the full report, visit https://ibn.fm/Vcsgx About Nutriband Inc. Nutriband is primarily engaged in the development…

TuesdayJul 01, 2025 9:20 am

QualityStocksNewsBreaks – Golden Triangle Ventures Inc. (OTC: GTVH) Restructures $7 Million in Legacy Debt, Secures Repurchase Option

Golden Triangle Ventures (OTC: GTVH) (“GTV”) has completed a major restructuring of its capital structure and legacy debt obligations through an agreement with a new third-party investor, who acquired all outstanding notes previously held by the Company’s largest creditor, T&K Zarro, LLC. The transaction consolidates five debt instruments totaling over $7 million and grants GTVH the exclusive right to repurchase the full balance for $4 million, offering a significant discount. The move simplifies GTVH’s balance sheet, supports disciplined growth and strengthens financial positioning. To view the full press release, visit https://ibn.fm/ynhAO About Golden Triangle Ventures Inc. Golden Triangle Ventures is a…

TuesdayJul 01, 2025 9:10 am

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Amends Payment Schedule for Iska Iska Interest, Updates Adjacent Property Agreement

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) has reached a mutual agreement with Empresa Minera Villegas S.R.L. to amend the payment terms for acquiring 100% interest in the Iska Iska silver-tin polymetallic project in southern Bolivia. Of the remaining US$4.45 million owed, US$1.8 million in exploration spending on the adjacent Mina Casiterita property will be credited, with cash payments of US$1 million due July 15, 2025, and US$1.65 million due January 6, 2026. The related Mina Casiterita and Mina Hoyada option agreement has also been revised, calling for a US$1.8 million payment within 12 months of securing mining rights…

TuesdayJul 01, 2025 9:00 am

Dynamic Global Events Presents: The 6th Clinical Trial Agreements Summit

Dynamic Global Events (“DGE”) is proud to announce the 6th Clinical Trial Agreements Summit taking place August 21-22 in Philadelphia. This event will explore how to negotiate budgetary restraints, protect intellectual property and clinical data, and reduce risks in indemnification and subject injury. This summit offers a dynamic mix of panel discussions, fireside chats, solo presentations, and exclusive networking opportunities with top stakeholders across the clinical research industry. Hear from 30+ expert speakers representing leading organizations including Merck, Pfizer, Takeda, Alkermes, and many more. As clinical trial agreements form the foundation of every collaboration between sponsors, sites, and CROs, it’s essential…

Site Search

Company Search

Month: July 2025